임상 유전체학 시퀀싱, 바이오뱅크 및 데이터베이스 서비스 시장 기회 및 전략(-2035년)

Clinical genomics sequencing, biobank, and database services collectively represent an integrated set of offerings focused on decoding genetic information, preserving biological samples, and managing complex genomic and clinical data for diagnostic, therapeutic, research, and public health applications. This comprises the provision of genomic sequencing technologies that read and interpret deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), the systematic collection and storage of biospecimens in biobanks, and the maintenance and analysis of large-scale genomic and clinical databases through software and bioinformatics platforms.

The clinical genomics sequencing, biobank, database services market consists of sales, by entities (organizations, sole traders, or partnerships), of advanced genomic technologies and infrastructure. Clinical genomics sequencing involves high-throughput DNA analysis, such as whole-genome or exome sequencing, diagnosis of rare diseases, guide cancer treatments, and enable precision medicine by identifying patient-specific genetic variants. Biobanks provide secure storage, processing, and distribution of biospecimens such as blood, tissue, and DNA samples, linked to clinical data for research and therapeutic development. Database services manage vast genomic datasets with encryption and tracking systems, ensuring privacy-compliant access for researchers worldwide.

The global clinical genomics sequencing, biobank, database services market was valued at $3,927.1 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 15.00%.

Rising Prevalence Of Diseases With Genetic Components

During the historic period, the clinical genomics sequencing, biobank, database services market was significantly driven by the rising prevalence of diseases with genetic components. As conditions such as cancer, inherited metabolic disorders, cardiovascular diseases, and neurological disorders were increasingly understood to have genetic underpinnings, healthcare systems and researchers placed greater emphasis on identifying genetic risk factors, disease mechanisms, and molecular pathways. This shift accelerated the adoption of clinical genomics sequencing to support accurate diagnosis, prognosis, and treatment selection. For example, in February 2023, according to a study conducted at Rady Children's Hospital in San Diego, included 546 infants (112 infant deaths [20.5%] and 434 infants [79.5%] with acute illness who survived) who underwent diagnostic whole-genome sequencing (WGS) between Jan. 2015 and Dec. 2020. Infants underwent WGS either premortem or postmortem with semiautomated phenotyping and diagnostic interpretation. Therefore, the clinical genomics sequencing, biobank, database services market was significantly driven by the rising prevalence of diseases with genetic components.

Integration Of AI-Designed Genome Editing With Clinical-Grade iPSC Manufacturing

Major companies in the market are focusing on integrating AI-designed genome editing with clinical-grade iPSC manufacturing to generate highly standardized, disease-relevant cellular models that can be sequenced at scale. This integration increases demand for high-depth clinical genomics sequencing to validate edits, characterize genetic stability, and support regulatory submissions. It also drives biobank expansion, as AI-engineered, GMP-aligned iPSC lines are stored, cataloged, and reused across multiple research and therapeutic programs. In parallel, database service providers benefit from the need to manage complex multi-omic, provenance, and longitudinal datasets linked to these engineered cell lines. Collectively, these dynamics strengthen the role of sequencing, biobank, and data platforms as foundational infrastructure for translational and precision medicine. For example, in January 2026, REPROCELL, a US-based biotechnology company, announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1(TM), an AI-designed genome editing system licensed from Profluent (Emeryville, CA, USA). StemEdit encompasses REPROCELL's proprietary clinical gene-editing technology and its new gene-edited iPSC lines that are ready for immediate use. These offerings combine REPROCELL's StemRNA(TM) Clinical iPSC Seed Clones, with OpenCRISPR-1(TM) enabled engineering workflows, ensuring a GMP-aligned, traceable, and regulatory-ready platform from the outset.

The global clinical genomics sequencing, biobank, database services market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 25.30% of the total market in 2024.

Clinical Genomics Sequencing, Biobank, Database Services Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global clinical genomics sequencing, biobank, database services market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 13 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for clinical genomics sequencing, biobank, database services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical genomics sequencing, biobank, database services market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider clinical genomics sequencing, biobank, database services market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by funding type, by disease area, by service type and by end-user.
• Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Regional And Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
• Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each by funding type, by disease area, by service type and by end-user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
• Regional Market Size And Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Europe, Rest of the World (ROW) within each region.
• Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking Briefs on the financials comparison between major players in the market.
• Competitive Dashboard Briefs on competitive dashboard of major players.
• Key Mergers And Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations This section includes recommendations for clinical genomics sequencing, biobank, database services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Markets Covered:

• 1) By Funding Type: Government-Sponsored; Commercial Services
• 2) By Disease Area: Oncology; Rare Genetic Disorders; Infectious Diseases; Reproductive Health; Other Disease Areas
• 3) By Service Type: Clinical Genomics Sequencing; Biobank Services; Database And Bioinformatics Services
• 4) By End-User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes And Universities; Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Other End Users
• Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; BGI Genomics Co. Ltd.; Eurofins Scientific SE; Quest Diagnostics Inc.
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; France; Germany; UK; Italy; Spain; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; clinical genomics sequencing, biobank, database services indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Clinical Genomics Sequencing, Biobank, Database Services - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Clinical Genomics Sequencing, Biobank, Database Services Market Definition And Segmentations
• 6.4 Market Segmentation By Funding Type
  • 6.4.1 Government-Sponsored
  • 6.4.2 Commercial Services
• 6.5 Market Segmentation By Disease Area
  • 6.5.1 Oncology
  • 6.5.2 Rare Genetic Disorders
  • 6.5.3 Infectious Diseases
  • 6.5.4 Reproductive Health
  • 6.5.5 Other Disease Areas
• 6.6 Market Segmentation By Service Type
  • 6.6.1 Clinical Genomics Sequencing
  • 6.6.2 Biobank Services
  • 6.6.3 Database And Bioinformatics Services
• 6.7 Market Segmentation By End-User
  • 6.7.1 Hospitals And Clinics
  • 6.7.2 Diagnostic Laboratories
  • 6.7.3 Research Institutes And Universities
  • 6.7.4 Pharmaceutical And Biotechnology Companies
  • 6.7.5 Contract Research Organizations (CROs)
  • 6.7.6 Other End Users

7 Major Market Trends

• 7.1 Integration Of AI-Designed Genome Editing With Clinical-Grade iPSC Manufacturing
• 7.2 Growth Of Commercial Genomic Data Platforms Offering Subscription-Based And Partnership-Driven Access Models
• 7.3 Adoption Of Cloud-Based Secure Genomic Data Access And Analysis Environments For Multi-Stakeholder Collaboration
• 7.4 Rising Demand For Clinically Interpretable And Regulatory-Grade Genomic Sequencing Services
• 7.5 Integration Of Multi-Omics Data With Clinical Genomics And Longitudinal Health Records
• 7.6 Collaborative Integration Of Longitudinal Clinical And Genomic Datasets To Enable Advanced Insights Across Populations
• 7.7 Institutional Investment In Scalable Biobank Resources To Support Precision Medicine
• 7.8 Advancement Toward Multi-Modal, High-Throughput Spatial Biology Systems
• 7.9 Standardization And Interoperability Of Clinical Genomic Databases Across Healthcare And Research Systems

8 Global Clinical Genomics Sequencing, Biobank, Database Services Growth Analysis And Strategic Analysis Framework

• 8.1 Global Clinical Genomics Sequencing, Biobank, Database Services PESTEL Analysis
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End Users (B2C Market)
  • 8.2.1 Hospitals And Clinics
  • 8.2.2 Diagnostic Laboratories
  • 8.2.3 Research Institutes And Universities
  • 8.2.4 Pharmaceutical And Biotechnology Companies
  • 8.2.5 Contract Research Organizations (CROs)
  • 8.2.6 Other End Users

9 Information On Value Propositions For Different Customers (End Users) And Specific Use Cases In Clinical Genomics Sequencing, Biobank, Database Services Market

• 9.1 Hospitals & Clinics-Value Proportions
  • 9.1.1 Rapid, Accurate Genomic Diagnosis To Inform Treatment Decisions
  • 9.1.2 Personalized Medicine Enablement
  • 9.1.3 Clinical Decision Support Via Integrated Genomic Reports Tied To Guidelines & Evidence
• 9.2 Diagnostic Laboratories-Value Proportions
  • 9.2.1 Access To Specialist Sequencing Infrastructure Without Heavy Capital Investment
  • 9.2.2 High-Throughput Sequencing And Panel Testing Capabilities With Reliable Bioinformatics
  • 9.2.3 Faster Turnaround Times And Standardized Reporting For Clinical Use
• 9.3 Research Institutes & Universities-Value Proportions
  • 9.3.1 Access To Cutting-Edge Sequencing Technologies For Hypothesis-Driven Research
  • 9.3.2 Supports Population Genomics, Functional Genomics, And Translational Studies
• 9.4 Pharmaceutical & Biotechnology Companies-Value Proportions
  • 9.4.1 Speeds Drug Target Discovery And Biomarker Identification Via Genomic Insights
  • 9.4.2 Supports Patient Stratification And Companion Diagnostic Development
  • 9.4.3 Reduces R&D Risk By Informing Mechanism And Therapeutic Response Prediction
• 9.5 Contract Research Organizations (CROs)-Value Proportions
  • 9.5.1 Enables Outsourced Sequencing Workflows Integrated Into Study Protocols
  • 9.5.2 Provides Regulatory-Ready Genomics Data For Trial Sponsors
• 9.6 Other End Users-Value Proportions
  • 9.6.1 Population Health Surveillance & Policy
  • 9.6.2 Consumer Health & Wellness Insights

10 Information On Maturity Of Clinical Genomics Sequencing, Biobank, Database Services Market

• 10.1 Clinical Genomics Sequencing Market - Emerging to Growth Stage
• 10.2 Biobank Services Market - Growth / Expansion Stage
• 10.3 Database Services & Bioinformatics Market - Growth / Fast-Evolving Stage

11 Information On Opportunities And Challenges For Newer Players In The Clinical Genomics Sequencing, Biobank, Database Services Market

• 11.1 Opportunities for Newer Players
  • 11.1.1 Rising Demand Across Clinical And Research Applications
  • 11.1.2 AI & Machine Learning-Enabled Platforms
  • 11.1.3 Multi-Omics And Integrated Analytic Services
  • 11.1.4 Cloud-Based And SaaS Bioinformatics Platforms
  • 11.1.5 Biobank Data Linkages And Digital Infrastructure
  • 11.1.6 Direct-To-Consumer (DTC) Awareness Spillover
• 11.2 Challenges & Barriers For Newer Players
  • 11.2.1 High Capital And Infrastructure Costs
  • 11.2.2 Skilled Talent Shortage
  • 11.2.3 Data Privacy, Security & Ethical Oversight
  • 11.2.4 Standardization & Interoperability Gaps
  • 11.2.5 Market Entrenchment & High Switching Costs
  • 11.2.6 Price Sensitivity & Reimbursement Limitations

12 Explicitly Assess Successful And Unsuccessful Models, With Case-Based Insights

• 12.1 deCODE Genetics (Amgen)
• 12.2 Genomics England
• 12.3 Helix (United States)
• 12.4 23andMe
• 12.5 AncestryDNA (Blackstone)
• 12.6 UK Biobank
• 12.7 Guardant Health

13 Pharmaceutical And Biotechnology Companies Actively Utilizing Genomic, Biobank And Database Services

14 Global Clinical Genomics Sequencing, Biobank, Database Services Market Growth Rate Analysis

• 14.1 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 14.1.1 Market Drivers 2020 - 2025
  • 14.1.2 Market Restraints 2020 - 2025
• 14.2 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
  • 14.2.1 Market Drivers 2025 - 2030
  • 14.2.2 Market Restraints 2025 - 2030
• 14.3 Total Addressable Market for the Clinical Genomics Sequencing, Biobank, Database Services Market - Business to Customer (B2C)
  • 14.3.1 TAM Comparison Analysis

15 Global Clinical Genomics Sequencing, Biobank, Database Services Market Segmentation

• 15.1 Global Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.2 Global Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.3 Global Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 Global Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Clinical Genomics Sequencing, Biobank, Database Services Market, Regional and Country Analysis

• 16.1 Global Clinical Genomics Sequencing, Biobank, Database Services Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Asia-Pacific Market

• 17.1 Market Overview
  • 17.1.1 Region Information
  • 17.1.2 Market Information
  • 17.1.3 Background Information
  • 17.1.4 Government Initiatives
  • 17.1.5 Regulations
  • 17.1.6 Regulatory Bodies
  • 17.1.7 Major Associations
  • 17.1.8 Taxes Levied
  • 17.1.9 Corporate Tax Structure
  • 17.1.10 Investments
  • 17.1.11 Major Companies
• 17.2 Asia Pacific Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.3 Asia Pacific Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Asia Pacific Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Asia Pacific Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.6 Asia-Pacific Clinical Genomics Sequencing, Biobank, Database Services Market: Country Analysis
• 17.7 China Market
• 17.8 Market Overview
  • 17.8.1 Country Information
  • 17.8.2 Market Information
  • 17.8.3 Background Information
  • 17.8.4 Government Initiatives
  • 17.8.5 Regulations
  • 17.8.6 Regulatory Bodies
  • 17.8.7 Major Associations
  • 17.8.8 Taxes Levied
  • 17.8.9 Corporate Tax Structure
  • 17.8.10 Investments
  • 17.8.11 Major Companies
• 17.9 China Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.10 China Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.11 China Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.12 China Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.13 India Market
• 17.14 India Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.15 India Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.16 India Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.17 India Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.18 Japan Market
• 17.19 Market Overview
  • 17.19.1 Country Information
  • 17.19.2 Market Information
  • 17.19.3 Background Information
  • 17.19.4 Government Initiatives
  • 17.19.5 Regulations
  • 17.19.6 Regulatory Bodies
  • 17.19.7 Major Associations
  • 17.19.8 Taxes Levied
  • 17.19.9 Corporate Tax Structure
  • 17.19.10 Investments
  • 17.19.11 Major Companies
• 17.20 Japan Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.21 Japan Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.22 Japan Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.23 Japan Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.24 South Korea Market
• 17.25 Market Overview
  • 17.25.1 Country Information
  • 17.25.2 Market Information
  • 17.25.3 Background Information
  • 17.25.4 Government Initiatives
  • 17.25.5 Regulations
  • 17.25.6 Regulatory Bodies
  • 17.25.7 Major Associations
  • 17.25.8 Taxes Levied
  • 17.25.9 Corporate Tax Structure
  • 17.25.10 Investments
  • 17.25.11 Major Companies
• 17.26 South Korea Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.27 South Korea Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.28 South Korea Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.29 South Korea Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.30 Australia Market
• 17.31 Australia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.32 Australia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.33 Australia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.34 Australia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.35 Indonesia Market
• 17.36 Indonesia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.37 Indonesia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.38 Indonesia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.39 Indonesia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Europe Market

• 18.1 Market Overview
  • 18.1.1 Region Information
  • 18.1.2 Market Information
  • 18.1.3 Background Information
  • 18.1.4 Government Initiatives
  • 18.1.5 Regulations
  • 18.1.6 Regulatory Bodies
  • 18.1.7 Major Associations
  • 18.1.8 Taxes Levied
  • 18.1.9 Corporate tax structure
  • 18.1.10 Investments
  • 18.1.11 Major Companies
• 18.2 Europe Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.3 Europe Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.4 Europe Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.5 Europe Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.6 Europe Clinical Genomics Sequencing, Biobank, Database Services Market: Country Analysis
• 18.7 UK Market
• 18.8 UK Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.9 UK Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.10 UK Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.11 UK Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.12 Germany Market
• 18.13 Germany Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.14 Germany Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.15 Germany Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.16 Germany Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.17 France Market
• 18.18 France Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.19 France Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.20 France Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.21 France Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.22 Italy Market
• 18.23 Italy Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.24 Italy Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.25 Italy Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.26 Italy Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.27 Spain Market
• 18.28 Spain Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.29 Spain Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.30 Spain Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.31 Spain Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.32 Russia Market
• 18.33 Russia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.34 Russia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.35 Russia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 18.36 Russia Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

19 USA Market

• 19.1 Market Overview
  • 19.1.1 Country Information
  • 19.1.2 Market Information
  • 19.1.3 Background Information
  • 19.1.4 Government Initiatives
  • 19.1.5 Regulations
  • 19.1.6 Regulatory Bodies
  • 19.1.7 Major Associations
  • 19.1.8 Taxes Levied
  • 19.1.9 Corporate Tax Structure
  • 19.1.10 Investments
  • 19.1.11 Major Companies
• 19.2 USA Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.3 USA Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.4 USA Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 19.5 USA Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

20 Rest Of The World Market

• 20.1 Market Overview
  • 20.1.1 Region Information
  • 20.1.2 Market Information
  • 20.1.3 Background Information
  • 20.1.4 Government Initiatives
  • 20.1.5 Regulations
  • 20.1.6 Regulatory Bodies
  • 20.1.7 Major Associations
  • 20.1.8 Taxes Levied
  • 20.1.9 Corporate Tax Structure
  • 20.1.10 Investments
  • 20.1.11 Major Companies
• 20.2 Rest Of The World Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Funding Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.3 Rest Of The World Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Disease Area, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.4 Rest Of The World Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By Service Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 20.5 Rest Of The World Clinical Genomics Sequencing, Biobank, Database Services Market, Segmentation By End Users, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

21 Competitive Landscape And Company Profiles

• 21.1 Company Profiles
• 21.2 Illumina Inc
  • 21.2.1 Company Overview
  • 21.2.2 Products And Services
  • 21.2.3 Business Strategy
  • 21.2.4 Financial Overview
• 21.3 Thermo Fisher Scientific Inc
  • 21.3.1 Company Overview
  • 21.3.2 Products And Services
  • 21.3.3 Business Strategy
  • 21.3.4 Financial Overview
• 21.4 BGI Genomics Co. Ltd
  • 21.4.1 Company Overview
  • 21.4.2 Products and Services
  • 21.4.3 Business Strategy
  • 21.4.4 Financial Overview
• 21.5 Eurofins Scientific SE
  • 21.5.1 Company Overview
  • 21.5.2 Products And Services
  • 21.5.3 Business Strategy
  • 21.5.4 Financial Overview
• 21.6 Quest Diagnostics Inc
  • 21.6.1 Company Overview
  • 21.6.2 Products and Services
  • 21.6.3 Financial Overview

22 Other Major And Innovative Companies

• 22.1 Hamilton Company
  • 22.1.1 Company Overview
  • 22.1.2 Products and Services
• 22.2 Invitae Corp
  • 22.2.1 Company Overview
  • 22.2.2 Products and Services
• 22.3 Tempus AI Inc
  • 22.3.1 Company Overview
  • 22.3.2 Products and Services
• 22.4 Novogene Corporation
  • 22.4.1 Company Overview
  • 22.4.2 Products and Services
• 22.5 23andMe Holding Inc
  • 22.5.1 Company Overview
  • 22.5.2 Products and Services

23 Competitive Benchmarking

24 Competitive Dashboard

25 Key Mergers And Acquisitions

• 25.1 SeqOne Acquired Congenica
• 25.2 QIAGEN Acquired Genoox
• 25.3 Regeneron Pharmaceuticals Acquired 23andMe's Biobank and Genetics Services
• 25.4 Mapmygenome Acquired Microbiome Insights
• 25.5 GeneDx Acquired Fabric Genomics

26 Recent Developments In Clinical Genomics Sequencing, Biobank, Database Services

• 26.1 Accelerating Genomic Drug Discovery Through AI-Powered Inference Platforms and Pharma Co-Development Models
• 26.2 Expanding Population-Scale Clinico-Genomic Databases Through Strategic Pharma-Platform Collaborations
• 26.3 Strengthening National Genomics Infrastructure Through Government-Backed Longitudinal Biobanking Initiatives

27 Opportunities And Strategies

• 27.1 Global Clinical Genomics Sequencing, Biobank, Database Services Market In 2030 - Countries Offering Most New Opportunities
• 27.2 Global Clinical Genomics Sequencing, Biobank, Database Services Market In 2030 - Segments Offering Most New Opportunities
• 27.3 Global Clinical Genomics Sequencing, Biobank, Database Services Market In 2030 - Growth Strategies
  • 27.3.1 Market Trend Based Strategies
  • 27.3.2 Competitor Strategies

28 Clinical Genomics Sequencing, Biobank, Database Services Market, Conclusions And Recommendations

• 28.1 Conclusions
• 28.2 Recommendations
  • 28.2.1 Product
  • 28.2.2 Place
  • 28.2.3 Price
  • 28.2.4 Promotion
  • 28.2.5 People

29 Appendix

• 29.1 Geographies Covered
• 29.2 Market Data Sources
• 29.3 Research Methodology
• 29.4 Currencies
• 29.5 The Business Research Company
• 29.6 Copyright and Disclaimer